July’s “ESR of the month”: James Heald



In July we feature our seventh ESR of the month: James Heald!

James works in Maria Berdasco’s lab at the Josep Carreras Leukaemia Research Institute carrying out Project 6 within the INTERCEPT-MDS network. He is analysing the efficiency of epigenetic drugs as a mechanism to decrease aberrant histone methylation activity in myelodysplastic syndrome (MDS) and secondary acute myeloid leukaemia (sAML). 

To learn more about James and his project, watch his video below and stay tuned for more content during July!